TORONTO, Jan. 11 /CNW/ - Theralase(TM) Technologies Inc. (TSX-V: TLT & OTC BB: TLTFF) (“Theralase”), a designer, manufacturer and distributor of therapeutic medical laser systems, announced today that, effective December 21, 2007, its Board of Directors appointed PricewaterhouseCoopers LLP, Chartered Accountants (“Pricewaterhouse”) as the Company’s new independent auditors, replacing the firm of Collins Barrow, Chartered Accountants (“Collins Barrow”).
